Feeding With Indirect Calorimetry and Cycling in the Elderly (FICE)

July 24, 2023 updated by: National University Hospital, Singapore

Feeding With Indirect Calorimetry and Cycling in the Elderly Intensive Care Patient

The aim of this study is to evaluate the effect of early exercise by cycle ergometry and early targeted feeding in reducing muscle atrophy and improve functional outcomes in the older critically ill patient.

Study Overview

Detailed Description

Patients admitted to ICU are normally ventilated due to their critical illness and sedated for their comfort. This prolonged immobility from sedation leads to accelerated muscle atrophy and reconditioning when they recover from their critical illness. This leads to further complications from immobility like bed sores, hospital acquired infections, deep vein thrombosis and pulmonary embolisms. Many patients do not return to their pre-illness level of function and require long term care.

Nutrition is frequently hard to assess when patients is in a catabolic state and sedated. There is a loss of appetite if the patient is awake to express it, and if sedated is depended on nasogastric feeding based on caloric empirical formulas invented more than 50 years ago. These formulas also do not accurately take into account exercise physiotherapy which patients will undergo while on ICU. With indirect calorimetry (IC), patients energy requirements can be estimated on a daily basis and can be fed accordingly. The IC is considered the gold standard in many guidelines for nutritional assessments but it is not commonly used due to cost and practical difficulties in measurements. The investigators intend to use the IC based on international recommendations to assess energy requirements daily and feed patients based on the data provided by the IC.

Early rehabilitative type of exercises have been show to increase muscle mass and reduce length of stay in the elderly geriatric population by preventing deconditioning. There is some evidence that this also applies to the ICU population but in a ventilated patient on multiple therapies, this is extremely labour intensive. By utilising the cycle ergometry, this muscle atrophy may be reduced. Interestingly, studies on intensive physiotherapy have not shown to have a dramatic outcome in the elderly ICU population. This could be due to the catabolic rates and the inadequate feeding of a sedated patient who cannot express their hunger or satiety. By using the indirect calorimetry, a more accurate energy expenditure can be estimated and nutrition can be targeted. By combining these 2 therapies, the lengths of stay in hospital can be reduced and functional outcomes improved in this silver population.

The investigators plan to conduct a randomised controlled trial. Participants will be randomised into 2 groups; the intervention and control group. Participants in the control group will receive standard empiric weight based feeding and standard physiotherapy. Participants in the intervention group will undergo daily IC measurements on admission and fed according to the energy expenditure measured by IC. In addition to standard physiotherapy, the participants in the intervention group will undergo cycle ergometry for up to 60 minutes daily. The participants in the intervention group will undergo 14 days of IC and cycle ergometry or until extubation (for IC), whichever is earlier.

During this 14 day period, participants in both groups will undergo twice weekly quadriceps muscle ultrasounds to assess muscle thickness as a surrogate measure of muscle atrophy. After this 14 day period, the investigators will perform regular assessments of functional status (during the ICU/HD stay, on discharge to general ward, and on discharge from hospital). The investigators will also collect demographic and ICU assessment data from medical records.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Singapore, Singapore, 119074
        • National University Health System

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. At least 60 years old
  2. Mechanically ventilated within 3 days of ICU admission
  3. Expected to be mechanically ventilated for more than 3 days at time of recruitment
  4. Able to ambulate with or without a gait aid before hospitalization
  5. Able to be enterally fed within 48 hours of ICU admission

Exclusion Criteria:

  1. Unable to follow commands at baseline before hospital admission (e.g. Severe dementia)
  2. Acute condition where cycling is a contraindication (e.g. leg fracture)
  3. Not expected to survive the subsequent 48 hours
  4. Body habitus unable to fit the cycle ergometry
  5. Patients at high risk of refeeding (i.e. NUTRIC score >= 5): malnourished patients with anorexia nervosa, chronic malabsorption syndromes, chronic alcoholism, or patients with massive weight loss.
  6. Extremes of BMI: i.e. BMI < 16 or > 30
  7. Liver failure
  8. Cycling exemptions precluding cycling within the first 4 days of mechanical ventilation
  9. Requirement for inspired oxygen content (FiO2) greater than 0.8
  10. Expected to be on renal replacement therapy for longer than 12 hours per session
  11. PEEP > 15mmHg
  12. Air leaks through chest drains
  13. Palliative goals of care or limitation of treatment established by the CARE form
  14. Readmissions to ICU

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: 1. Control
  • Standard physiotherapy
  • Empiric formula directed feeding (daily caloric requirement calculated by 25 kcal/kg/day)
Active Comparator: 2. Intervention
  • Up to 60 minutes of cycle ergometry daily in addition to standard physiotherapy sessions.
  • Indirect calorimetry directed feeding (use of indirect calorimetry to calculate daily caloric requirement)
Indirect calorimetry directed feeding (use of indirect calorimetry to calculate daily caloric requirement)
Up to 60 minutes of cycle ergometry daily in addition to standard physiotherapy sessions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in quadriceps muscle thickness
Time Frame: Change in thickness of quadriceps muscle (as assessed by ultrasound scanning) over the first 2 weeks of study.
Change in quadriceps muscle thickness
Change in thickness of quadriceps muscle (as assessed by ultrasound scanning) over the first 2 weeks of study.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MRC-ss
Time Frame: On discharge from ICU, up to 1 year from recruitment.
Measurement of functional outcome.
On discharge from ICU, up to 1 year from recruitment.
MRC-ss
Time Frame: 14 days after recruitment
Measurement of functional outcome.
14 days after recruitment
MRC-ss
Time Frame: On discharge from hospital, up to 1 year from recruitment.
Measurement of functional outcome.
On discharge from hospital, up to 1 year from recruitment.
FSS-ICU
Time Frame: On discharge from ICU, up to 1 year from recruitment.
Measurement of functional outcome.
On discharge from ICU, up to 1 year from recruitment.
FSS-ICU
Time Frame: 14 days after recruitment
Measurement of functional outcome.
14 days after recruitment
FSS-ICU
Time Frame: On discharge from hospital, up to 1 year from recruitment.
Measurement of functional outcome.
On discharge from hospital, up to 1 year from recruitment.
CPax
Time Frame: On discharge from ICU, up to 1 year from recruitment.
Measurement of functional outcome.
On discharge from ICU, up to 1 year from recruitment.
CPax
Time Frame: 14 days after recruitment
Measurement of functional outcome.
14 days after recruitment
CPax
Time Frame: On discharge from hospital, up to 1 year from recruitment.
Measurement of functional outcome.
On discharge from hospital, up to 1 year from recruitment.
Quadriceps strength and hand grip strength
Time Frame: On discharge from ICU, up to 1 year from recruitment.
Measured with dynamometer.
On discharge from ICU, up to 1 year from recruitment.
Quadriceps strength and hand grip strength
Time Frame: 14 days after recruitment
Measured with dynamometer.
14 days after recruitment
Quadriceps strength and hand grip strength
Time Frame: On discharge from hospital, up to 1 year from recruitment.
Measured with dynamometer.
On discharge from hospital, up to 1 year from recruitment.
Length of Stay in ICU
Time Frame: Day of discharge from ICU, up to 1 year from recruitment.
Length of Stay in ICU
Day of discharge from ICU, up to 1 year from recruitment.
Length of hospital stay
Time Frame: Day of discharge from hospital, up to 1 year from recruitment.
Length of hospital stay
Day of discharge from hospital, up to 1 year from recruitment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Will NH Loh, MBBS, National University Hospital, Singapore

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 6, 2017

Primary Completion (Estimated)

June 30, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

January 31, 2018

First Submitted That Met QC Criteria

May 16, 2018

First Posted (Actual)

May 30, 2018

Study Record Updates

Last Update Posted (Actual)

July 27, 2023

Last Update Submitted That Met QC Criteria

July 24, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscular Atrophy

Clinical Trials on Indirect Calorimetry directed feeding.

3
Subscribe